S&P Upgrades BioMed Realty Trust, Inc. (BMR) to 'BBB'

BioMed Realty Trust, Inc. (NYSE: BMR) announced that its investment grade corporate credit rating from Standard & Poor's Ratings Services ("S&P") has been upgraded from BBB– to BBB. BioMed Realty was the first real estate investment trust dedicated to the life science industry to receive investment grade corporate credit ratings from S&P and Moody's Investors Service ("Moody's") in April 2010. The company received positive outlooks from S&P and Moody's in June 2013 and March 2014, respectively.

"We view our investment grade corporate credit rating as one of the key drivers of our capital strategy and a competitive advantage in pursuing strategic growth opportunities," said Greg N. Lubushkin, Chief Financial Officer of BioMed Realty. "We are pleased that S&P has upgraded our rating to BBB, which further enhances our long-term financial flexibility as we continue to build on our proven track record of creating value for our tenant partners and stockholders."

You May Also Be Interested In

• Inhibikase Therapeutics (IKT) Issues Letter to Shareholders and Provides Update on Development Programs
• Rocket Lab USA (RKLB) Announces Board Change
• Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises